Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H12O5 |
| Molecular Weight | 284.2635 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(O)C=C3O
InChI
InChIKey=DANYIYRPLHHOCZ-UHFFFAOYSA-N
InChI=1S/C16H12O5/c1-20-11-4-2-9(3-5-11)14-8-13(19)16-12(18)6-10(17)7-15(16)21-14/h2-8,17-18H,1H3
| Molecular Formula | C16H12O5 |
| Molecular Weight | 284.2635 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Acacetin is an O-methylated flavone that exhibits anti-inflammatory, anti-nociceptive, neuroprotective, and anti-aromatase properties. It is a naturally occurring plant metabolite which can be found in Robinia pseudoacacia, Turnera diffusa, Betula pendula, and Asplenium normale. Acacetin has been investigated in a number of in-vitro and animal models for various cancers, and neurological disorders including Alzheimer's disease.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22447574
Curator's Comment: referenced study was conducted in mice
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P11511 Gene ID: 1588.0 Gene Symbol: CYP19A1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/18948180 |
18.7 µM [IC50] | ||
Target ID: GO:0001525 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23943785 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Atmospheric-pressure molecular imaging of biological tissues and biofilms by LAESI mass spectrometry. | 2010-09-03 |
|
| Redox regulation in cancer: a double-edged sword with therapeutic potential. | 2010-08-19 |
|
| Antiviral flavonoids from Mosla scabra. | 2010-07 |
|
| Acacetin inhibits TPA-induced MMP-2 and u-PA expressions of human lung cancer cells through inactivating JNK signaling pathway and reducing binding activities of NF-kappaB and AP-1. | 2010-05-25 |
|
| Blechnum orientale Linn - a fern with potential as antioxidant, anticancer and antibacterial agent. | 2010-04-30 |
|
| [Chemical constituents from flowers of Chrysanthemum indicum]. | 2010-03 |
|
| Flavonoid glycosides of the black locust tree, Robinia pseudoacacia (Leguminosae). | 2010-03 |
|
| CYP1A inhibition in fish gill filaments: a novel assay applied on pharmaceuticals and other chemicals. | 2010-01-31 |
|
| [Determination of quercetin, luteolin, apigenin and acacetin in Flos Chrysanthemi Indici by RP-HPLC]. | 2010-01 |
|
| Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway. | 2010-01 |
|
| In vitro antileishmanial, antiplasmodial and cytotoxic activities of phenolics and triterpenoids from Baccharis dracunculifolia D. C. (Asteraceae). | 2009-12 |
|
| CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells. | 2009-10-29 |
|
| [Simultaneous determination of six flavonoids in Flos Chrysanthemi Indici by RP-HPLC]. | 2009-08 |
|
| The methoxylated flavones eupatorin and cirsiliol induce CYP1 enzyme expression in MCF7 cells. | 2009-08 |
|
| From functional food to medicinal product: systematic approach in analysis of polyphenolics from propolis and wine. | 2009-07-22 |
|
| [Chemical constituents from herb of Solanum lyratum]. | 2009-07 |
|
| Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: a structure-function relationship study. | 2009-07 |
|
| Quantitative determination of flavonoids by column high-performance liquid chromatography with mass spectrometry and ultraviolet absorption detection in Artemisia afra and comparative studies with various species of Artemisia plants. | 2009-06-03 |
|
| [Studies on antibacterial constituents of Discocleidion rufescens (2)]. | 2009-06 |
|
| Correlation between antiangiogenic activity and antioxidant activity of various components from propolis. | 2009-05 |
|
| Trihydroxynaphthalene reductase of Curvularia lunata--a target for flavonoid action? | 2009-03-16 |
|
| Exudate flavonoids of some Juglandaceae. | 2009-02 |
|
| [Studies on chemical constituents of Dendranthema indicum var. aromaticum]. | 2009-01 |
|
| Antiproliferative effects of honey and of its polyphenols: a review. | 2009 |
|
| Comparison of intraperitoneal honey and sodium hyaluronate-carboxymethylcellulose (Seprafilm) for the prevention of postoperative intra-abdominal adhesions. | 2009 |
|
| Flavonoid-induced morphological modifications of endothelial cells through microtubule stabilization. | 2009 |
|
| Perturbation of the lipid phase of a membrane is not involved in the modulation of MRP1 transport activity by flavonoids. | 2009 |
|
| Analysis of flavonoids in propolis and Ginkgo biloba by micellar electrokinetic capillary chromatography. | 2008-12-24 |
|
| Anti-aromatase activity of the constituents from damiana (Turnera diffusa). | 2008-12-08 |
|
| Metabolic modifications of birch leaf phenolics by an herbivorous insect: detoxification of flavonoid aglycones via glycosylation. | 2008-11-13 |
|
| Anti-inflammatory and immunosuppressive effect of flavones isolated from Artemisia vestita. | 2008-10-30 |
|
| Chemical composition and botanical origin of red propolis, a new type of brazilian propolis. | 2008-09 |
|
| Strategies for prostate cancer prevention: Review of the literature. | 2008-07 |
|
| Common dietary flavonoids inhibit the growth of the intraerythrocytic malaria parasite. | 2008-06-18 |
|
| Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs. | 2008-05-13 |
|
| Anticomplementary principles of a Chinese multiherb remedy for the treatment and prevention of SARS. | 2008-05-08 |
|
| [Studies on chemical constituents from flowers of Chrysanthemum indicum]. | 2008-05 |
|
| [Water-soluble constituents from roots of Capparis tenera]. | 2008-05 |
|
| Bioactive aristolactams from Piper umbellatum. | 2008-05 |
|
| [Studies on chemical constituents in Huangjuhua (flowers of Chrysanthemum morifolium)]. | 2008-03 |
|
| [Study on flavonoiels and phenolic acids from the herb of Lygodium japonicum]. | 2008-02 |
|
| Comparative antioxidant activity and HPLC profiles of some selected Korean thistles. | 2008-01 |
|
| Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism. | 2008 |
|
| Antimicrobial phenolic derivatives from Dendranthema zawadskii var. latilobum Kitamura (Asteraceae). | 2007-11 |
|
| Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship. | 2007-11 |
|
| Flavonoids, anti-inflammatory activity and cytotoxicity of Macfadyena unguis-cati L. | 2007-10-27 |
|
| Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondria-mediated death signaling and SAPK/JNK1/2-c-Jun activation. | 2007-08-31 |
|
| [Chemical constituents from roots Pseudostellaria heterophylla]. | 2007-06 |
|
| Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. | 2007 |
|
| [Studies on flavonoid constituents from herbs of Artemisia ordosica II]. | 2006-12 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23943785
Male Swiss albino mice were subcutaneously injected with 500 micro-L of Matrigel alone or with VEGF (50 ng/mL) and/or acacetin (25 or 50 mg/kg bw). Mice were sacrificed 14 days later and the Matrigel plugs were removed, weighed and measured. Acacetin strongly suppressed VEGF-induced angiogenic growth into the Matrigel plugs after two weeks of treatment.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18948180
Aromatase was isolated from HepG2 cell lysates and prepared in a reaction mixture consisting of 5 l of 50 mM NADPH, 5 l [1-3H]-androst-4-ene-3,17-dione and 80 micro-L cell lysate (100 - 200 micro-g/mL of protein) with 10 microL of purified acacetin (1 - 50 micro-M). The reaction was initiated at 37 ◦C by addition of NADPH to the reaction mixtures and the incubation was continued for 1 h. The enzyme reaction was terminated by adding 500 l of chloroform. The mixture was immediately centrifuged and the aqueous layer extracted for scintillation counting. Acacetin showed potent inhibition of aromatase with an IC50 of 18.7 micro-M.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:58:12 GMT 2025
by
admin
on
Mon Mar 31 18:58:12 GMT 2025
|
| Record UNII |
KWI7J0A2CC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
3988 (Number of products:14)
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
76061
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY | |||
|
207-552-3
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY | |||
|
KWI7J0A2CC
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY | |||
|
100000127488
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY | |||
|
DTXSID00197383
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY | |||
|
15335
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY | |||
|
57284
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY | |||
|
SUB33514
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY | |||
|
ACACETIN
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY | |||
|
C023717
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY | |||
|
480-44-4
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY | |||
|
m1284
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY | Merck Index | ||
|
5280442
Created by
admin on Mon Mar 31 18:58:12 GMT 2025 , Edited by admin on Mon Mar 31 18:58:12 GMT 2025
|
PRIMARY |